Mylan Technologies, Inc. et al. vs MonoSol Rx, LLC et al.

Transcript of Patent Trial and Appeal Board Hearing on October 4, 2017

Patent Owner MonoSol Rx, LLC's Updated Exhibit List

Termination Decision Document

Petitioner's Update Exhibit List

REPLACEMENT - Exhibit 1030 - Confidential Settlement Agreement

Order Conduct of the Proceeding

Exhibit 1030 - Confidential Settlement Agreement

Joint Request to File as Business Confidential

Joint Motion to Terminate

Order - Granting Petitioner's Motion for Admission Pro Hac Vice of Mr. Tung-On Kong and Ms. Elham F. Steiner - 37 CFR 42.10(c)

Petitioner's Notice of Deposition of Robert S. Langer

Petitioner's Motion for Pro Hac Vice Admission

Exhibit 1028 - Declaration of T.O. Kong ISO Motion for PHV Admission

Exhibit 1029 - Declaration of Elham Steiner ISO Motion for PHV Admission

Petitioner Mylan Technologies Inc.¿¿¿s Notice of Objections to Evidence

Deposition Transcript of Dr. Graham Buckton

U.S. Provisional App. Ser. No. 60/443,741

Patent Owner Response

Declaration of Dr. Robert Langer

Perumal 2007 Masters thesis

Morales article

Langer CV

C.A. No. 1:14-cv-01451-RGA, Trial Transcript

Siepmann article

Compos-Aldrete article

De Muth article

Yoo article

Ahmed article

Amnuaikit article

James E. De Muth, Basic Statistics and Pharmaceutical Statistical Applications (1st ed. 1999)

Lachman Book-The Theory and Practice of Industrial Pharmacy

Puttipipatkhachorn article

Staniforth article

Perugini article

Dhanikula article

U.S. Patent No. 7,425,292

Sigma-Aldrich Product Information Sheet re Caffeine (Anhydrous)

Shakeel article

USP 905 (2002)

Wheeler article

David S. Jones, Pharmaceutical Statistics (2002)

Updated Mandatory Notices by Patent Owner

Patent Owner's Notice of Deposition of Graham Buckton, Ph.D.

Patent Owner MonoSol Rx, LLC's Amended Power of Attorney

Petitioner Mylan Technologies Inc.'s Notice of Objection to Evidence

Trial Instituted Document

Scheduling Order

Preliminary Response to Petition for Inter Partes Review of US Patent No. 8,603,514

Perumal article

Kathpalia article

Reckitt Benckiser v. Watson Trial Transcript

Reckitt Benckiser v. Watson Trial Opinion

McConville article

Borges article

Power of Attorney

Mandatory Notices by Patent Owner

Notice of Accord Filing Date

Exhibit 1003 - CV of Graham Buckton

Power of Attorney

Exhibit 1001 - US 8,603,514 to Yang et al

Exhibit 1004 - File History of US 8,603,514 - Part 2 of 3

Exhibit 1006 - WO0042992 to Chen et al

Exhibit 1004 - File History of US 8,603,514 - Part 1 of 3

Exhibit 1004 - File History of US 8,603,514 - Part 3 of 3

Exhibit 1005 - Ilango et al

Exhibit 1008 - Frankman et al

Exhibit 1007 - Declaration of B. Arlie Bogue

Exhibit 1010 - Roddy et al

Exhibit 1011 - US 4,569,837 to Suzuki et al

Exhibit 1012 - US 6,159,498 to Tapolsky et al

Exhibit 1013 - Yamamura et al

Exhibit 1015 - US 4,568,535 to Loesche

Exhibit 1016 - US 3,797,494 to Zaffaroni

Exhibit 1017 - US 4,249,531 to Heller et al

Exhibit 1025 - Memorandum Order in 14-1451

Exhibit 1027 - Complaint, No. 1-15-cv-01016

Exhibit 1009 - US 5,595,980 to Brode et al

Exhibit 1014 - US 4,713,243 to Schiraldi et al

Exhibit 1018 - US 5,506,049 to Swei et al

Exhibit 1019 - US 7,067,116 to Bess et al

Exhibit 1020 - US 4,849,246 to Schmidt

Exhibit 1021 - EP0241178 to Higashi et al

Exhibit 1022 - United States Pharmacopeia

Exhibit 1023 - Trial Opinion in 13-1674

Exhibit 1024 - Memorandum Order in 13-1674

Exhibit 1026 - Complaint, No. 1-15-cv-00209

Exhibit 1002 - Declaration of Graham Buckton, Ph.D

Petition for Inter Partes Review of US 8,603,514